It was decided to cancel the listing of Kyongnam Pharma, which is well-known as 'Lemonade'.
The Korea Exchange held a corporate judging committee yesterday (14th) and decided this way.
The KSE will open the KOSDAQ market committee by January 8, next month, and decide whether to cancel the listing.
Gyeongnam Pharmaceutical was found to be subject to a fair examination of the eligibility for listing by violating the accounting standards in the investigation by the financial authorities.
Lemona abolishes listing of Kyongnam Pharmaceutical
2018-12-15T09:01:40.257Z
It was decided to cancel the listing of Kyongnam Pharma, which is well-known as 'Lemonade'. The Korea Exchange held a corporate judging committee yesterday and made this decision. The KSE will open the KOSDAQ market committee by January 8, next month, and decide whether to cancel the listing.
Source: sbskr